Immediate Hypersensitivity to Contrast Agents: The French 5-year CIRTACI Study
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Immediate Hypersensitivity to Contrast Agents: The French 5-year CIRTACI Study |
| Type de publication | Journal Article |
| Year of Publication | 2018 |
| Auteurs | Clement O, Dewachter P, Mouton-Faivre C, Nevoret C, Guilloux L, Morot EBloch, Katsahian S, Laroche D, Audebert M, Benabes-Jezraoui B, Benoit Y, Beot S, Berard F, Berthezene Y, Bertrand P, Bouffard J, Bourrain J-L, Boyer B, Carette M-F, Caron-Poitreau C, Cavestri B, Cercueil JPierre, Charpin D-A, Collet E, Crombe-Ternamian A, Dalmas J, Decoux E, Defrance M-F, Delaval Y, Demoly P, Depriester C, Depriester P, Didier A, Drouet M, Dupas B, Dupre-Goetchebeur D, Dzviga C, Fabre C, Ferretti G, Fourre-Jullian C, Girardin P, Giron J, Gouitaa M, Grenier N, Bilbault LGuenard, Guez S, Gunera-Saad N, Heautot J-F, Herbin D, Hoarau C, Jacquot C, Julien C, Laborie L, Lambert C, Larroche P, Leclerc X, Lemaitre L, Leynadier F, Lillo-Le-Louet A, Louvel J-P, Louvier N, Lucas M-M, Meites G, Mennesson N, Metge L, Meunier Y, Monnier-Cholley L, Musacchio M, Nicolie B, Occelli G, Oesterle H, Paisant-Thouveny F, Panuel M, Railhac N, Rety-Jacob F, Rochefort-Morel C, Roy C, Sarlieve P, Sesay M, Sgro C, Taourel P, Terrier P, Theissen O, Topenot I, Valfrey J, Veillon F, Vergnaud M-C, Veyret C, Vincent D, Wallaert B, Wessel F, Zins M, Study CIRTACI |
| Journal | ECLINICALMEDICINE |
| Volume | 1 |
| Pagination | 51-61 |
| Date Published | JUL |
| Type of Article | Article |
| Résumé | Background: Iodinated and gadolinium-based contrastmedia (ICM; GBCM) induce immediate hypersensitivity (IH) reactions. Differentiating allergic from non-allergic IH is crucial; allergy contraindicates the culprit agent for life. We studied frequency of allergic IH among ICM or GBCM reactors. Methods: Patients were recruited in 31 hospitals between 2005 and 2009. Clinical symptoms, plasma histamine and tryptase concentrations and skin tests were recorded. Allergic IH was diagnosed by intradermal tests (IDT) with the culprit CM diluted 1:10, ``potentially allergic'' IH by positive IDT with pure CM, and non-allergic IH by negative IDT. Findings: Among 245 skin-tested patients (ICM = 209; GBCM = 36), allergic IH to ICM was identified in 41 (19.6%) and to GBCM in 10 (27.8%). Skin cross-reactivity was observed in 11 patients with ICM (26.8%) and 5 with GBCM (50%). Allergy frequency increased with clinical severity and histamine and tryptase concentrations (p < 0.0001). Cardiovascular signs were strongly associated with allergy. Non-allergic IH was observed in 152 patients (62%) (ICM:134; GBCM:18). Severity grade was lower (p < 0.0001) and reaction delay longer (11.6 vs 5.6 min; p < 0.001). Potentially allergic IH was diagnosed in 42 patients (17.1%) (ICM:34; GBCM:8). The delay, severity grade, and mediator release were intermediate between the two other groups. Interpretation: Allergic IH accounted for <10% of cutaneous reactions, and >50% of life-threatening ones. GBCM and ICM triggered comparable IH reactions in frequency and severity. Cross-reactivity was frequent, especially for GBCM. We propose considering skin testing with pure contrast agent, as it is more sensitive than the usual 1:10 dilution criteria. (C) 2018 Published by Elsevier Ltd. |
| DOI | 10.1016/j.eclinm.2018.07.002 |